تقرير
أعرض في EDS

Can lithium be used in the setting of clozapine commencement in patients with COVID-19 associated neutropenia: A case report.

التفاصيل البيبلوغرافية
العنوان: Can lithium be used in the setting of clozapine commencement in patients with COVID-19 associated neutropenia: A case report.
المؤلفون: Tan JQE; SA Pharmacy, Flinders Medical Centre Southern Adelaide Local Health Network Adelaide South Australia Australia.; College of Medicine and Public Health Flinders University Adelaide South Australia Australia., Dawson JL; SA Pharmacy, Flinders Medical Centre Southern Adelaide Local Health Network Adelaide South Australia Australia.; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences Monash University Parkville Victoria Australia., Bastiampillai T; Discipline of Psychiatry, College of Medicine and Public Health Flinders University Adelaide South Australia Australia.; Department of Psychiatry Monash University Clayton Victoria Australia.
المصدر: Clinical case reports [Clin Case Rep] 2024 Apr 12; Vol. 12 (4), pp. e8758. Date of Electronic Publication: 2024 Apr 12 (Print Publication: 2024).
نوع المنشور: Case Reports
اللغة: English
بيانات الدورية: Publisher: John Wiley & Sons Country of Publication: England NLM ID: 101620385 Publication Model: eCollection Cited Medium: Print ISSN: 2050-0904 (Print) Linking ISSN: 20500904 NLM ISO Abbreviation: Clin Case Rep Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Chichester, UK : John Wiley & Sons
مستخلص: COVID-19 infection may increase the likelihood of neutropenia in patients already on clozapine. In clozapine treated patients experiencing COVID-19 associated neutropenia, adjunct therapy with lithium can be considered.
(© 2024 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.)
References: Noro Psikiyatr Ars. 2023 May 02;60(2):99-103. (PMID: 37287549)
Front Pharmacol. 2020 Aug 27;11:557629. (PMID: 32973537)
BMJ Case Rep. 2021 May 12;14(5):. (PMID: 33980567)
Medicine (Baltimore). 2021 Nov 12;100(45):e27694. (PMID: 34766570)
BMJ. 2020 Mar 16;368:m1071. (PMID: 32179567)
Front Pharmacol. 2022 Apr 14;13:850583. (PMID: 35496309)
Am J Pathol. 2021 Jan;191(1):4-17. (PMID: 32919977)
Signal Transduct Target Ther. 2020 Jul 25;5(1):128. (PMID: 32712629)
J Psychiatry Neurosci. 2021 Mar 11;46(2):E232-E237. (PMID: 33703870)
Front Pharmacol. 2021 Apr 16;12:658734. (PMID: 33959025)
Prim Care Companion CNS Disord. 2018 Nov 29;20(6):. (PMID: 30549484)
Clin Case Rep. 2024 Apr 12;12(4):e8758. (PMID: 38617070)
CNS Drugs. 2007;21(1):25-35. (PMID: 17190527)
Int J Bipolar Disord. 2020 May 20;8(1):21. (PMID: 32435920)
Ther Adv Psychopharmacol. 2016 Feb;6(1):33-8. (PMID: 26913176)
Ann Hematol. 2020 Nov;99(11):2477-2482. (PMID: 32815018)
Medicina (Kaunas). 2022 Jan 18;58(2):. (PMID: 35208467)
World J Biol Psychiatry. 2004 Oct;5(4):230-4. (PMID: 15543518)
Schizophr Bull. 2023 Jan 3;49(1):53-67. (PMID: 36242537)
Gen Psychiatr. 2020 Apr 16;33(2):e100183. (PMID: 32420521)
BMC Res Notes. 2014 Sep 12;7:635. (PMID: 25214394)
J Blood Med. 2022 Oct 31;13:631-641. (PMID: 36405428)
J Clin Psychiatry. 2006 May;67(5):756-60. (PMID: 16841625)
Acta Psychiatr Scand. 2018 Aug;138(2):101-109. (PMID: 29786829)
Aust Prescr. 2020 Jun;43(3):91-93. (PMID: 32675910)
Clin Case Rep. 2020 Oct 26;8(12):3349-3351. (PMID: 33363932)
Ther Adv Psychopharmacol. 2022 Mar 5;12:20451253211072341. (PMID: 35273789)
Rev Psiquiatr Salud Ment (Engl Ed). 2022 Apr-Jun;15(2):134-137. (PMID: 35840279)
Pharmacogenomics. 2019 Mar;20(4):279-290. (PMID: 30767710)
Clin Psychopharmacol Neurosci. 2021 Aug 31;19(3):411-422. (PMID: 34294611)
Adv Lab Med. 2022 Oct 13;3(4):383-396. (PMID: 37363430)
Brain Behav Immun Health. 2021 May;13:100212. (PMID: 33527097)
Neuropsychiatr Dis Treat. 2022 May 04;18:977-983. (PMID: 35547265)
Sci Rep. 2021 Nov 2;11(1):21519. (PMID: 34728719)
Int J Clin Pract. 2021 Aug;75(8):e14441. (PMID: 34289643)
Pak J Med Sci. 2021 Sep-Oct;37(5):1435-1439. (PMID: 34475926)
BMC Psychiatry. 2023 Mar 15;23(1):170. (PMID: 36922799)
J Med Virol. 2020 Sep;92(9):1533-1541. (PMID: 32181903)
فهرسة مساهمة: Keywords: COVID‐19; antipsychotics; clozapine; neutropenia; psychiatry
تواريخ الأحداث: Date Created: 20240415 Latest Revision: 20240425
رمز التحديث: 20240425
مُعرف محوري في PubMed: PMC11014804
DOI: 10.1002/ccr3.8758
PMID: 38617070
قاعدة البيانات: MEDLINE
الوصف
تدمد:2050-0904
DOI:10.1002/ccr3.8758